Krystexxa 8MG

Ended Awarded

Contract number
36C24524N0796
Awardee
Awarding agency
Obligated
$74,667

Award facts

Contract value 100% obligated
$74,667.32 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
La Vergne, TN 37086, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the delivery of KRYSTEXXA 8MG, a specialty pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Horizon Therapeutics USA, Inc., a global biotechnology company that specializes in rare, autoimmune, and inflammatory disease treatments.

The $74,667.32 firm fixed-price delivery order was placed against Horizon's existing Pharmaceuticals and Drugs (FSS-61-IB) Multiple Award Schedule contract with the General Services Administration (GSA), which has a term from August 2019 through August 2025. Horizon also holds a $18 million Blanket Purchase Agreement (BPA) against the same GSA schedule, covering the procurement of several of the company's orphan and specialty drugs including KRYSTEXXA. This contract does not have a set-aside designation. The delivery order is intended to support healthcare services for veterans through the VA's Veterans Health Administration (VHA) and its regional Veterans Integrated Service Networks (VISNs).

Quick answers

Who was awarded contract 36C24524N0796?

36C24524N0796 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 5, 2024.

How much is contract 36C24524N0796 worth?

The government has obligated $74,667 on 36C24524N0796.

Is contract 36C24524N0796 an order under another contract?

Yes. 36C24524N0796 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24524N0796 competed?

The extent of competition for 36C24524N0796 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award